
|Videos|July 14, 2021
Dr. Wong on treatment sequence in metastatic urothelial carcinoma
Author(s)Urology Times staff
Risa Wong, MD, discusses the sequencing of treatments in the metastatic urothelial carcinoma armamentarium, including chemotherapy, immune checkpoint inhibitors, and antibody-drug conjugates.
Advertisement
Risa Wong, MD, discusses the sequencing of treatments in the metastatic urothelial carcinoma armamentarium, including chemotherapy, immune checkpoint inhibitors, and antibody-drug conjugates. Wong is a hematology/oncology fellow at the University of Washington and Fred Hutchinson Cancer Research Center in Seattle.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA provides guidance on development pathway for testosterone therapy for women
2
Pearls & Perspectives: Leadership and Prostate Cancer, with Mark L. Gonzalgo, MD, PhD, MBA
3
Pedro Freitas, MD, on consolidative surgery vs prolonged systemic therapy in MIBC
4
Treatment Selection in Advanced Prostate Cancer
5






